6hgk - Revision history

OCA at 06:53, 31 July 2019

OCA — Wed, 31 Jul 2019 06:53:34 GMT

←Older revision		Revision as of 06:53, 31 July 2019
Line 3:		Line 3:
	<StructureSection load='6hgk' size='340' side='right'caption='[[6hgk]], [[Resolution\|resolution]] 1.85Å' scene=''>		<StructureSection load='6hgk' size='340' side='right'caption='[[6hgk]], [[Resolution\|resolution]] 1.85Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6hgk]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HGK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6HGK FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6hgk]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HGK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6HGK FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=STR:PROGESTERONE'>STR</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=STR:PROGESTERONE'>STR</scene></td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">SERPINA3, AACT, GIG24, GIG25 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6hgk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6hgk OCA], [http://pdbe.org/6hgk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6hgk RCSB], [http://www.ebi.ac.uk/pdbsum/6hgk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6hgk ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6hgk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6hgk OCA], [http://pdbe.org/6hgk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6hgk RCSB], [http://www.ebi.ac.uk/pdbsum/6hgk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6hgk ProSAT]</span></td></tr>
	</table>		</table>
Line 22:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Muller, Y A]]		[[Category: Muller, Y A]]

OCA at 06:07, 29 May 2019

OCA — Wed, 29 May 2019 06:07:51 GMT

←Older revision		Revision as of 06:07, 29 May 2019
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6hgk is ~~ON HOLD~~ ~~until Paper~~ Publication	+	==Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex with progesterone==
		+	<StructureSection load='6hgk' size='340' side='right'caption='[[6hgk]], [[Resolution\|resolution]] 1.85Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[6hgk]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HGK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6HGK FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=STR:PROGESTERONE'>STR</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6hgk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6hgk OCA], [http://pdbe.org/6hgk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6hgk RCSB], [http://www.ebi.ac.uk/pdbsum/6hgk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6hgk ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/AACT_HUMAN AACT_HUMAN]] Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2.<ref>PMID:2404007</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The introduction of ligand-binding sites into proteins and the engineering of molecular allosteric coupling pathways are topical issues in protein design. Here, we show that these issues can be addressed concurrently, using the serpin human alpha1-antichymotrypsin (ACT) as a model. We have introduced up to 15 amino acid substitutions into ACT, converting it into a surrogate corticosteroid-binding globulin (CBG), thereby creating a new binding globulin (NewBG). Human CBG and ACT share 46% sequence identity, and CBG served as the blue-print for our design, which was guided by side-chain-packing calculations, ITC measurements and crystal structure determinations. Upon transfer of ligand-interacting residues from CBG to ACT and mutation of specific second shell residues, a NewBG variant was obtained, which binds cortisol with 1.5microM affinity. This novel serpin (NewBG-III) binds cortisol with a 33-fold lower affinity than CBG, but shares a similar ligand-binding profile and binding mode when probed with different steroid ligands and site-directed mutagenesis. An additional substitution, i.e. A349R, created NewBG-III-allo, which introduced an allosteric coupling between ligand binding and the serpin-like S-to-R transition in ACT. In NewBG-III-allo, the proteinase-triggered S-to-R transition leads to a greater than 200-fold reduction in ligand affinity, and crystal structures suggest that this is mediated by the L55V and A349R substitutions. This reduction significantly exceeds the 10-fold reduction in binding affinity observed in human CBG.

-	~~Authors~~: ~~Schmidt~~, K., Muller, Y.A.	+	NewBG: A surrogate corticosteroid-binding globulin with an unprecedentedly high ligand release efficacy.,Gardill BR, Schmidt K, Muller YA J Struct Biol. 2019 May 16. pii: S1047-8477(19)30110-8. doi:, 10.1016/j.jsb.2019.05.006. PMID:31103428<ref>PMID:31103428</ref>

-	~~Description: Crystal structure~~ of ~~Alpha1~~-~~antichymotrypsin variant NewBG~~-~~III~~: ~~a new binding globulin in complex with progesterone~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
-	[[Category: Muller, Y.A]]	+	<div class="pdbe-citations 6hgk" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Muller, Y A]]
	[[Category: Schmidt, K]]		[[Category: Schmidt, K]]
		+	[[Category: Alpha1-antichymotrypsin]]
		+	[[Category: Computational protein design]]
		+	[[Category: Serpin]]
		+	[[Category: Transport protein]]

OCA at 08:44, 5 September 2018

OCA — Wed, 05 Sep 2018 08:44:17 GMT

←Older revision		Revision as of 08:44, 5 September 2018
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6hgk is ON HOLD	+	The entry 6hgk is ON HOLD until Paper Publication

	Authors: Schmidt, K., Muller, Y.A.		Authors: Schmidt, K., Muller, Y.A.

OCA: Protected "6hgk" [edit=sysop:move=sysop]

OCA — Wed, 29 Aug 2018 06:01:43 GMT

Protected "6hgk" [edit=sysop:move=sysop]

←Older revision

Revision as of 06:01, 29 August 2018

OCA: New page: '''Unreleased structure''' The entry 6hgk is ON HOLD Authors: Schmidt, K., Muller, Y.A. Description: Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globu...

OCA — Wed, 29 Aug 2018 06:01:41 GMT

New page: '''Unreleased structure''' The entry 6hgk is ON HOLD Authors: Schmidt, K., Muller, Y.A. Description: Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globu...

New page

'''Unreleased structure'''

The entry 6hgk is ON HOLD

Authors: Schmidt, K., Muller, Y.A.

Description: Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex with progesterone
[[Category: Unreleased Structures]]
[[Category: Muller, Y.A]]
[[Category: Schmidt, K]]